Suggestions
Avi Kulkarni
CEO at ThoughtSphere, an AI-first Clinical Data and Analytics Platform leader; Independent Director (NED) at Diaceutics
Dr. Avi Kulkarni is the recently appointed Chief Executive Officer of ThoughtSphere, an AI-first Clinical Data & Analytics Platform provider.1 He joined the company in May 2024, bringing with him extensive experience in the life sciences industry and a proven track record of driving growth and innovation.1
Professional Background
Prior to joining ThoughtSphere, Dr. Kulkarni held several prominent positions in the healthcare and life sciences sector:
- President of Global Clinical Sales at Syneos Health (June 2023 - May 2024)2
- Senior Vice President of Life Sciences Business Unit and Industry Solutions at Cognizant (March 2022 - June 2023)2
- Managing Director at Accenture (January 2020 - May 2021)2
- Principal (Partner) at KPMG, LLP (December 2017 - November 2019)2
- SVP and Managing Director at QuintilesIMS (now IQVIA) (October 2014 - November 2017)2
- Vice President (Partner) at Booz & Company (April 2012 - October 2014)2
Education and Expertise
Dr. Kulkarni holds a Ph.D., likely from Stanford University Graduate School of Business, based on his LinkedIn profile.2 His areas of expertise include:
- Clinical research and development
- Personalized medicine and companion diagnostics
- R&D optimization
- Life sciences strategy
- Digital transformation in healthcare
Role at ThoughtSphere
As CEO of ThoughtSphere, Dr. Kulkarni is responsible for:
- Spearheading strategic initiatives
- Driving innovation in clinical operations and biometrics
- Expanding market reach
- Enhancing platform capabilities
- Delivering exceptional customer experiences1
Dr. Kulkarni's appointment comes at a time when ThoughtSphere is positioning itself as a leader in Clinical Data and Analytics, with a focus on providing real-time, customer-focused data at scale.1